You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
EverQuote, Inc. (EVER) - free report >>
Vertex, Inc. (VERX) - free report >>
Immunocore Holdings PLC Sponsored ADR (IMCR) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 7th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Artivion, Inc. (AORT - Free Report) : This medical device and tissue engineering company has seen the Zacks Consensus Estimate for its current year earnings increasing 68.2% over the last 60 days.
Artivion, Inc. Price and Consensus
Artivion, Inc. price-consensus-chart | Artivion, Inc. Quote
Vertex, Inc. (VERX - Free Report) : This tax technology solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 8.6% over the last 60 days.
Vertex, Inc. Price and Consensus
Vertex, Inc. price-consensus-chart | Vertex, Inc. Quote
NextNav Inc. (NN - Free Report) : This positioning, navigation, and timing (PNT) solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
NextNav Inc. Price and Consensus
NextNav Inc. price-consensus-chart | NextNav Inc. Quote
Immunocore Holdings plc (IMCR - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 48.6% over the last 60 days.
Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore Holdings PLC Sponsored ADR price-consensus-chart | Immunocore Holdings PLC Sponsored ADR Quote
EverQuote, Inc. (EVER - Free Report) : This online marketplace company has seen the Zacks Consensus Estimate for its current year earnings increasing 19.7% over the last 60 days.
EverQuote, Inc. Price and Consensus
EverQuote, Inc. price-consensus-chart | EverQuote, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.